Back to funds

Commodore Capital LP

Updated 6 days ago

Managed by Commodore Capital Lp • Latest filing Q3 2026

Portfolio value
$1.3B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$1.5B
Q1 2026$1.7B
Q2 2026$1.7B
Q3 2026$1.3B

Top holdings

37 positions as of Q3 2026

View filing
R

RELAY THERAPEUTICS INC

Value
$216.6M
Shares
12.00M
% Port
16.78%
E

ENLIVEN THERAPEUTICS INC

Value
$150.1M
Shares
3.27M
% Port
11.63%
A

ALKERMES PLC

Value
$116.5M
Shares
2.88M
% Port
9.03%
A

ALTO NEUROSCIENCE INC

Value
$69.5M
Shares
2.72M
% Port
5.39%
S

SPYRE THERAPEUTICS INC

Value
$62.3M
Shares
700.0K
% Port
4.83%
A

AMYLYX PHARMACEUTICALS INC

Value
$58.2M
Shares
2.00M
% Port
4.51%
L

LB PHARMACEUTICALS INC

Value
$49.2M
Shares
1.28M
% Port
3.81%
?
8.N/A

DAMORA THERAPEUTICS INC

Value
$41.3M
Shares
1.94M
% Port
3.20%
C

COGENT BIOSCIENCES INC

Value
$40.5M
Shares
1.26M
% Port
3.14%
T

TYRA BIOSCIENCES INC

Value
$37.7M
Shares
1.73M
% Port
2.92%
C

CELLDEX THERAPEUTICS INC NEW

Value
$32.4M
Shares
1.00M
% Port
2.51%
P

PHARVARIS N V

Value
$29.3M
Shares
925.0K
% Port
2.27%
?
13.N/A

SURROZEN INC

Value
$28.5M
Shares
885.0K
% Port
2.21%
K

KORSANA BIOSCIENCES INC

Value
$28.1M
Shares
877.0K
% Port
2.17%
S

SAGIMET BIOSCIENCES INC

Value
$27.2M
Shares
2.76M
% Port
2.11%
D

DEFINIUM THERAPEUTICS INC

Value
$26.6M
Shares
700.0K
% Port
2.06%
A

ADARX PHARMACEUTICALS INC

Value
$25.1M
Shares
1.26M
% Port
1.95%
E

EDITAS MEDICINE INC

Value
$22.8M
Shares
8.89M
% Port
1.77%
E

ENTERA BIO LTD

Value
$21.4M
Shares
7.35M
% Port
1.66%
?
20.N/A

ATTOVIA THERAPEUTICS INC

Value
$19.9M
Shares
1.16M
% Port
1.54%

Explore